Image
|
Figure Caption
Fig. 8 CHNQD-00824 inhibited tumor growth in zebrafish. (A) Zebrafish model of liver cancer. When development reached 3 dpf, zebrafish were treated with DOX (60 mg/L) and CHNQD-00824 (1.25–5 μM) to 7 dpf. Sorafenib as positive control. (B) Tumor size in zebrafish was measured by photography at 7 dpf. The data shown are the mean ± SD (**** p < 0.0001, ## p < 0.01, #### p < 0.0001, and ns, nonsignificant). n = 3 biological replicate samples.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Mar. Drugs